What the surgeon of the future needs to read today…
Surgical Innovation: Advances in Minimally Invasive Surgical Science, Technology, and Training focuses on the revolution that minimally invasive surgical techniques, new instruments such as laparoscopes and endoscopes, and new technologies have brought to the art, science, and business of surgery. This innovative publication prepares both new and experienced surgeons to think and work in "the operating room of the future," while helping them to face the challenges of learning new techniques, understanding and adapting to new technologies, maintaining surgical competencies, and applying surgical outcomes data to their practices.
Each issue of Surgical Innovation: Advances in Minimally Invasive Surgical Science, Technology, and Training offers unique original articles from the vanguard of clinical practice, noteworthy basic and applied research from the basic sciences, state-of-the-art surgical education, and useful insights into the business of surgical practice. Written by leading international medical and surgical practitioners from specialties such as general surgery, gynecology, urology, cardiothoracic surgery, vascular surgery, head and neck surgery, neurosurgery, otolaryngology, orthopedics, and pediatric surgery, the perceptive and incisive articles highlight those practices and technologies that will change your practice today and revolutionize surgery for decades to come.
Surgical Innovation: Advances in Minimally Invasive Surgical Science, Technology, and Training covers rapidly emerging topics, often found nowhere else, including:
- New Procedures (for example, NOTES, image guided surgery)
- New Instruments
- Practice Management
- Cross-Specialty Synergies
Research on the Cutting Edge
- Energy Sources
- Operating Room of the Future
- Materials and Prostheses
- Biologic Investigations
- Surgical Training and Performance Metrics
- Surgical Simulation
- Introduction of New Techniques and Technologies into Clinical Practice
Surgical Innovation: Advances in Minimally Invasive Surgical Science, Technology, and Training is dedicated to becoming the core reference for the most advanced aspects of innovative surgical practice for the most innovative surgeons.
This journal is a member of the Committee on Publication Ethics (COPE)
Surgical Innovation: Advances in Minimally Invasive Surgical Science, Technology, and Training is dedicated to becoming the core reference for the most advanced aspects of innovative surgical practice for the most innovative surgeons. It focuses on the revolution that minimally invasive surgical techniques, new instruments such as laparoscopes and endoscopes, and new technologies have brought to the art, science, and business of surgery. Each issue of Surgical Innovation: Advances in Minimally Invasive Surgical Science, Technology, and Training offers unique original articles from the vanguard of clinical practice, noteworthy basic and applied research from the basic sciences, state-of-the-art surgical education, and useful insights into the business of surgical practice.
|Adrian E. Park, MD||Anne Arundel Health System, Annapolis, MD, USA|
|Lee Swanstrom, MD, FACS, FASGE, FRCSEng(hon))||Oregon Health and Sciences University; IHU-Strasbourg, USA|
|Mehran Anvari, MD||Director Centre for Minimal Access Surgery|
|Michael Bailey, MD||University of Sulley, Guildford, UK|
|John Birkmeyer, MD||Dartmouth-Hitchcock Health System, Lebanon, NH, USA|
|Alfred Cuschieri, MD||University of Dundee, UK|
|Bernard Dallemagne, MD||IRCAD, Strasbourg, France|
|Giovanni Dapri, MD||European School of Laparoscopic Surgery, Saint-Pierre University Hospital, Belgium|
|Ara Darzi, MD||St. Mary's Hospital, London, USA|
|Steve Eubanks, MD||Florida Hospital, USA|
|Charles J. Filipi, MD||Creighton University Medical Center, USA|
|Abe Fingerhut, MD||Centre Hospitalier Intercommunal, Poissy, France|
|Samuel R. G. Finlayson, MD||University of Utah, USA|
|James Fleshman, MD||Washington University, St Louis, USA|
|Dennis Fowler, MD||Weill Medical College of Cornell University, USA|
|Gerald M. Fried, MD||Montreal General Hospital, Canada|
|Toby Gordon, ScD.||Healthcare & Life Sciences MBA Programs; Johns Hopkins Carey Business School, USA|
|Robert H. Hawes, MD||Florida Hospital, USA|
|Todd Heniford, MD||Carolinas Medical Center, USA|
|Anthony N. Kalloo, MD||Johns Hopkins Hospital, Baltimore, MD, USA|
|Mousa Khoursheed, BMBCH, FRCS, FACS, FASMBS||Kuwait University, Kuwait|
|Thomas M. Krummel, MD, FACS/FAAP||Stanford University, USA|
|Antonio Lacy, MD||Hospital Clinic de Barcelona, Spain|
|Jacques Marescaux, MD||IRCAD, Strasbourg, France|
|Jeff Marks, MD||Case Western University, USA|
|Ulrich Matern, MD|
|Robin McLeod||University of Toronto, Canada|
|Scott Melvin, MD||Montefiore Medical Center, Bronx, NY, USA|
|Ninh T. Nguyen||University of California Irvine, CA, USA|
|Jeffrey Ponsky, MD||Cleveland Clinic, Cleveland, OH, USA|
|Todd Ponsky, MD||Case Western Reserve University, Cleveland, OH, USA|
|Dave Rattner, MD||Massachusetts General Hospital, USA|
|Michael Sarr, MD||Mayo Medical Center, USA|
|Steven Schwaitzberg, MD||Cambridge Health Alliance, Cambridge, MA, USA|
|Phil Shauer, MD||Cleveland Clinic, USA|
|Nathaniel J. Soper, MD||Northwestern University Feinberg School of Medicine, USA|
|Amir Szold, MD, FACS||Assia Medical Group, Tel Aviv, Israel|
|Eduardo M. Targarona, MD||Hospital de Sant Pau, Spain|
|Melinda Vassiliou, MD||McGill University, Canada|
|Steven Wexner, MD||Cleveland Clinic, Florida, USA|
|Manabu Yamamoto, MD||Adachi Kyosai Hospital, Tokyo, Japan|
SUBMIT YOUR MANUSCRIPT TODAY!
Surgical Innovation: Advances in Minimally Invasive Surgical Science, Technology, and Training is interested in publishing high quality manuscripts from a variety of surgical and engineering specialties. The common thread is innovative approaches or medical devices that further the frontiers of surgical care. We accept papers in the categories of original science, new technologies, innovations in surgical educations and reviews of new procedures or technologies. Reviews of well established approaches, procedures or technologies receive low priority. Small case series are accepted if they are well and ethically reported and represent advances in surgical care. We do not encourage submission of single case reports unless they are of earth-shaking import to the field of surgery (the first successful xenograph heart transplant, for instance). We encourage letters to the Editor commenting on published papers or topics of interest in the field of innovation. Letters to the Editor should be addressed to the editors, and should be 600 words or less. They should not have an abstract. The paper can have a maximum of 5 references, and one figure or a table.
Surgical Innovation: Advances in Minimally Invasive Surgical Science, Technology, and Training prefers to receive all manuscript submissions electronically. To submit a manuscript, please follow the instructions below or at http://mc.manuscriptcentral.com/sri.
Conditions of Publication
Authors are encouraged to submit review/original manuscripts that are not under consideration for publication elsewhere to the Journal for review. All manuscripts are subject to peer review to determine originality, validity, significance, and scientific value of the submitted material. Submitted manuscripts are peer reviewed by members of the Editorial Board or other experts chosen by the Editor. The Editor is responsible for final editing, decisions regarding acceptance, rejection and revisions. Submission of a manuscript to the Journal is taken as evidence that no portion of the text or figures has been copyrighted, published, or submitted for publication elsewhere, unless information regarding previous publication is cited and permission obtained. A copy of any such permissions obtained must accompany the manuscript. Upon acceptance of an article, the author(s) will be required to assign the copyright to the Publisher.
Manuscript Preparation. Manuscripts should be double-spaced with one-inch margins. Headings must be used to designate the major divisions of the paper. Pages should be numbered consecutively at the top of the manuscript. The surname of each author should appear in the upper left corner of each page, followed by a brief running title.
Title Page. Page one should include the title followed by the names and degrees of all authors as they will appear in print. This will be followed by a listing of the authors’ institutional affiliations. The title page should also include the name, address, telephone number, e-mail, and fax number of the corresponding author, and e-mail addresses for all co-authors. The author should cite if the paper was presented orally at a professional meeting, including the name of the meeting, date, and place. Credits and grant information supporting the research should also be listed if this study was supported by an agency.
Abstract. The abstract should appear at the beginning of the manuscript and should be no longer than 250 words in length. It should summarize the main points of the paper and be descriptive, narrative, and informative.
Tables. Tables should be double-spaced on pages separate from the text. Number tables consecutively with text and provide a table number and title for each. Hold length to one standard-sized manuscript page if possible. If a table continues past one page, repeat all heads and stub (left-hand) column. Tables should be numbered in order of citation in the text. Do not use photocopy reduction. Data in tables should not duplicate material in the text or illustrations. It is suggested to have no more than 3 tables and 5 figures.
Figure files must be submitted as separate files and are not to be embedded within the text file. Please use the following specifications for electronic figures:
- Authors are encouraged to use Adobe Illustrator and Adobe Photoshop to create graphics.
- Do not use Powerpoint or CorelDRAW. They print poorly on high-density printers. JPEG and TIFF files are preferred.
- The resolution for print must be at least 300 CPI. Low-resolution graphics cannot be published.
Medical Technology, Innovation and Invention
Papers discussing the process of commercializing a surgical innovation, e.g. securing intellectual property rights, determining freedom to operate, navigating barriers to entry, obtaining regulatory approval through the FDA or EMA or equivalent, getting CMS coverage determination, international trends and issues.
Expert Reviews, State of the Art Papers
Case studies- a description of the process of developing and potentially commercializing a surgical innovation, including such concepts as the steps in the process and the time frame, the key stakeholders, obstacles and challenges and how they were overcome, lessons learned of relevance to other innovators.
Research reports-analysis and key findings of issues related to the commercialization process, so as to identify constraining and promoting factors with respect to commercialization including as appropriate a literature review (potentially relevant literature is outside of the medical literature), discussion of methodology, findings and conclusions.
Review articles-expert review and discussion of relevant literature, law, and regulations as it pertains to aspects of the commercialization process and outcomes relevant to surgery, e.g. devices, instruments, information technology, methods and procedures.
Associated Costs for Authors
The charge for publishing color figures is $800 for the first figure and $200 for each additional figure.
Advertising and Reprints
Current advertising rates and specifications may be obtained by contacting the advertising coordinator at 805-410-7160 or by sending an e-mail to firstname.lastname@example.org. Reprints may be ordered by using the special reprint order form that will accompany author proofs. If you need another copy of this order form please e-mail email@example.com.
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
(i) made a substantial contribution to the concept and design, acquisition of data or analysis and interpretation of data,
(ii) drafted the article or revised it critically for important intellectual content,
(iii) approved the version to be published.
Please refer to the ICMJE Authorship guidelines at http://www.icmje.org/ethical_1author.html
Please provide a note specifying the role of each author in the research and writing of the article, in the following format:
Study concept and design:
Acquisition of data:
Analysis and interpretation:
Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.
All contributors who do not meet the criteria for authorship should be listed in an ‘Acknowledgements’ section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support. Authors should disclose whether they had any writing assistance and identify the entity that paid for this assistance.
To comply with the guidance for Research Funders, Authors and Publishers issued by the Research Information Network (RIN), SRIadditionally requires all Authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit Funding Acknowledgements on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding or state in your acknowledgments that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Declaration of conflicting interests
It is the policy of SRI to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please include any declaration at the end of your manuscript after any acknowledgements and prior to the references, under a heading ‘Conflict of interests’. If no declaration is made the following will be printed under this heading in your article: ‘None declared’. Alternatively, you may wish to state that ‘The Author(s) declare(s) that there is no conflict of interest’.
When making a declaration the disclosure information must be specific and include any financial relationship that all authors of the article has with any sponsoring organization and the for-profit interests the organization represents, and with any for-profit product discussed or implied in the text of the article.
Any commercial or financial involvements that might represent an appearance of a conflict of interest need to be additionally disclosed in the covering letter accompanying your article to assist the Editor in evaluating whether sufficient disclosure has been made within the Declaration of Conflicting Interests provided in the article.
For more information please visit the SAGE Journal Author Gateway.
All papers reporting animal and human studies must include whether written consent was obtained from the local Ethics Committee or Institutional Review Board. Please ensure that you have provided the full name and institution of the review committee and an Ethics Committee reference number.
We accept manuscripts that report human and/or animal studies for publication only if it is made clear that investigations were carried out to a high ethical standard. Studies in humans which might be interpreted as experimental (e.g. controlled trials) should conform to the Declaration of Helsinki http://www.wma.net/en/30publications/10policies/b3/index.htm and typescripts must include a statement that the research protocol was approved by the appropriate ethical committee. In line with the Declaration of Helsinki 1975, revised Hong Kong 1989, we encourage authors to register their clinical trials (at http://clinicaltrials.gov or other suitable databases identified by the ICMJE, http://www.icmje.org/publishing_10register.html). If your trial has been registered, please state this on the Title Page. When reporting experiments on animals, indicate on the Title Page which guideline/law on the care and use of laboratory animals was followed.
Authors are required to ensure the following guidelines are followed, as recommended by the International Committee of Medical Journal Editors, Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published.
Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note. When informed consent has been obtained it should be indicated in the submitted article.
As part of the submission process you will be asked to provide the names of peers who could be called upon to review your manuscript. Recommended reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below:
The reviewer should have no prior knowledge of your submission
The reviewer should not have recently collaborated with any of the authors
Reviewer nominees from the same institution as any of the authors are not permitted
Please note that the Editors are not obliged to invite any recommended/opposed reviewers to assess your manuscript.
Contributor’s publishing agreement
Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive license agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and license to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.
SRI and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of articles published in the journal. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked using duplication-checking software. Where an article is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or where authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article (removing it from the journal); taking up the matter with the head of department or dean of the author’s institution and/or relevant academic bodies or societies; banning the author from publication in the journal or all SAGE journals, or appropriate legal action.
Authors are responsible for obtaining permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.
English Language Services
Authors who want to refine the use of English in their manuscripts might consider utilizing the services of SAGE Language Services, which provides editing services to authors. SAGE Language Services specializes in editing and correcting English-language manuscripts written by authors with a primary language other than English. For more information, please visit http://languageservices.sagepub.com/en/.
As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.
The collection of ORCID iDs from corresponding authors is now part of the submission process of this journal. If you already have an ORCID iD you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID iD will become part of your accepted publication’s metadata, making your work attributable to you and only you. Your ORCID iD is published with your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.
If you or your funder wishes your article to be freely available online to nonsubscribers immediately upon publication (gold open access), you can opt for it to be included in SAGE Choice, subject to the payment of a publication fee. The manuscript submission and peer review procedure is unchanged. On acceptance of your article, you will be asked to let SAGE know directly if you are choosing SAGE Choice. To check journal eligibility and the publication fee, please visit SAGE Choice. For more information on open access options and compliance at SAGE, including self/author archiving deposits (green open access) visit SAGE Publishing Policies on our Journal Author Gateway.